siRNA AIMP2-DX2 inhibitor (Neomics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamesiRNA AIMP2-DX2 inhibitor (Neomics)
Drug Alias NamesiRNA AIMP2-DX2 inhibitor (Neomics/Daewoong)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAminoacyl tRNA synthase complex-interacting multifunctional protein 2 inhibitors
TargetsAminoacyl tRNA synthase complex-interacting multifunctional protein 2
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeomics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeomics Co LtdDaewoong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A